Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-André Becherel

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Archives of Dermatology|September 13, 2002
Vulvar lesion in a 45-year-old womanSophie Fraysse-Consigny, Olivier Chosidow, Pierre-André Becherel, et al.
Journal of Wound Care|February 16, 2019
Impregnated acetate gauze compared with lipido-colloid contact layer at dressing removal pain: a single-blind cross-over randomised control trialSylvie Meaume, Pierre Thomas, François Truchetet, et al.
Acta Dermato-Venereologica|February 7, 2019
Combining Omalizumab with Another BiotherapyAnne-Claire Fougerousse, Pierre-André Becherel, Valérie Pallure, et al.
European Journal of Dermatology : EJD|May 18, 2021
Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE studyFrançoise Giordano-Labadie, Pierre-André Becherel, Pauline Pralong, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 17, 2024
Evolution of dupilumab-associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO-ADOC study)Ziad Reguiai, Pierre André Becherel, Jean Luc Perrot, et al.
Orphanet Journal of Rare Diseases|February 8, 2025
Generalized pustular psoriasis: a multicentric study on patient characteristics and clinical burdenCristina Bulai Livideanu, Jérémy Gottlieb, Denis Jullien, et al.
Dermatology and Therapy|February 8, 2025
Implementation Science to Improve the Diagnosis and Management of Hidradenitis Suppurativa: HELyx Study Design OverviewJohn R Ingram, Georgios Kokolakis, Barry M McGrath, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 7, 2026
Dupilumab in moderate-to-severe prurigo nodularis: Real-world data from early access programMarie Jachiet, Clémentine Toussaint, Valérie Dorizy-Vuong, et al.
Acta Dermato-Venereologica|March 13, 2025
Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre StudyLaura Calabrese, Elisa Cinotti, Martina D'Onghia, et al.
Acta Dermato-Venereologica|October 6, 2023
Impact of Baricitinib on Patients' Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases RegistryZiad Reguiai, Pierre André Becherel, Jean Luc Perrot, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Archives of Dermatology|September 13, 2002
Vulvar lesion in a 45-year-old womanSophie Fraysse-Consigny, Olivier Chosidow, Pierre-André Becherel, et al.
Journal of Wound Care|February 16, 2019
Impregnated acetate gauze compared with lipido-colloid contact layer at dressing removal pain: a single-blind cross-over randomised control trialSylvie Meaume, Pierre Thomas, François Truchetet, et al.
Acta Dermato-Venereologica|February 7, 2019
Combining Omalizumab with Another BiotherapyAnne-Claire Fougerousse, Pierre-André Becherel, Valérie Pallure, et al.
European Journal of Dermatology : EJD|May 18, 2021
Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE studyFrançoise Giordano-Labadie, Pierre-André Becherel, Pauline Pralong, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 17, 2024
Evolution of dupilumab-associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO-ADOC study)Ziad Reguiai, Pierre André Becherel, Jean Luc Perrot, et al.
Orphanet Journal of Rare Diseases|February 8, 2025
Generalized pustular psoriasis: a multicentric study on patient characteristics and clinical burdenCristina Bulai Livideanu, Jérémy Gottlieb, Denis Jullien, et al.
Dermatology and Therapy|February 8, 2025
Implementation Science to Improve the Diagnosis and Management of Hidradenitis Suppurativa: HELyx Study Design OverviewJohn R Ingram, Georgios Kokolakis, Barry M McGrath, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 7, 2026
Dupilumab in moderate-to-severe prurigo nodularis: Real-world data from early access programMarie Jachiet, Clémentine Toussaint, Valérie Dorizy-Vuong, et al.
Acta Dermato-Venereologica|March 13, 2025
Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre StudyLaura Calabrese, Elisa Cinotti, Martina D'Onghia, et al.
Acta Dermato-Venereologica|October 6, 2023
Impact of Baricitinib on Patients' Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases RegistryZiad Reguiai, Pierre André Becherel, Jean Luc Perrot, et al.
Pageof 2